Cover Image

IL-13Rα2 Is Involved in Resistance to Doxorubicin and Survival of Osteosarcoma Patients

Background/Objectives: Interleukin 13 receptor alpha 2 (IL-13Rα2) is a receptor with a high affinity for IL-13 and is involved in the progression of human cancers. However, studies on the role of IL-13Rα2 in osteosarcoma are limited. Therefore, this study aimed to investigate the expression and role...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maryam Karamikheirabad (Author), Junyue Zhang (Author), Ae-Ri Ahn (Author), Ho Sung Park (Author), See-Hyoung Park (Author), Young Jae Moon (Author), Kyoung Min Kim (Author), Kyu Yun Jang (Author)
Format:	Book
Published:	MDPI AG, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum
by: Kyoung Min Kim, et al.
Published: (2021)

Special Issue "Osteosarcomas: Treatment Strategies"
by: See-Hyoung Park
Published: (2023)

Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma
by: Sung Woo Ahn, et al.
Published: (2020)

Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression
by: Jiayi Chen, et al.
Published: (2021)

Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex
by: Maxim A.X. Tollenaere, et al.
Published: (2023)

Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma
by: Renna Qiu, et al.
Published: (2020)

Analysis of Semen Parameters in α1,3-Galactosyltransferase-/- Boars
by: In-Sul Hwang, et al.
Published: (2017)

Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy
by: Yongshuang Li, et al.
Published: (2020)

Role of Phytochemicals in Treatment of Aging and Cancer: Focus on Mechanism of FOXO3 Activation
by: See-Hyoung Park
Published: (2024)

Aggressive Osteosarcoma of the Mandible in a 13-Year-Old Girl
by: Sajid S. Qureshi, et al.
Published: (2024)

Individual and co-expression patterns of nerve growth factor and heme oxygenase-1 predict shorter survival of gastric carcinoma patients
by: Sang Jae Noh, et al.
Published: (2017)

Association between Expression of 8-OHdG and Cigarette Smoking in Non-small Cell Lung Cancer
by: Ae Ri An, et al.
Published: (2019)

Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells
by: Xinru Wang, et al.
Published: (2024)

Fertility preservation for a 13-year-old male with relapsed osteosarcoma
by: Courtney J. Harris, et al.
Published: (2019)

Survival rate of pediatric osteosarcoma in Indonesia: a single center study
by: Hikari Ambara Sjakti, et al.
Published: (2021)

Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
by: Ruijia Liang, et al.
Published: (2022)

Sustained and Targeted Delivery of Self-Assembled Doxorubicin Nonapeptides Using pH-Responsive Hydrogels for Osteosarcoma Chemotherapy
by: Jie Zhu, et al.
Published: (2023)

Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo
by: Jinkui Wang, et al.
Published: (2022)

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
by: Evelien G. E. Hurkmans, et al.
Published: (2022)

A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
by: Rathore K, et al.
Published: (2015)

Doxorubicin-Loaded Lipid Nanoparticles Coated with Calcium Phosphate as a Potential Tool in Human and Canine Osteosarcoma Therapy
by: Daniela Chirio, et al.
Published: (2022)

IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
by: Julian S. Rechberger, et al.
Published: (2022)

The Effect of Nursing Simulation on the Clinical Judgment of Nursing Care for Patients with Increased Intracranial Pres-sure (IICP)
by: Ae Ri Jang, et al.
Published: (2021)

Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound
by: Jeongjin Lee, et al.
Published: (2022)

Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children
by: Haiping Ouyang, et al.
Published: (2022)

Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma
by: Jun Ah Lee, et al.
Published: (2019)

Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy
by: Chor Ho Jo, et al.
Published: (2018)

Liposomal Iron Oxide Nanoparticles Loaded with Doxorubicin for Combined Chemo-Photothermal Cancer Therapy
by: Taehoon Park, et al.
Published: (2023)

Osteosarcoma
by: Juan Pablo Zapata, et al.
Published: (2019)

Osteosarcoma
Published: (2012)

A five metastasis-related long noncoding RNA risk signature for osteosarcoma survival prediction
by: SiYuan Yu, et al.
Published: (2021)

LINC01116 Promotes Doxorubicin Resistance in Osteosarcoma by Epigenetically Silencing miR-424-5p and Inducing Epithelial-Mesenchymal Transition
by: Ran Li, et al.
Published: (2021)

Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis
by: Tang Y, et al.
Published: (2024)

Low‐grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw
by: Aya Sasaki, et al.
Published: (2021)

Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
by: Sujin Park, et al.
Published: (2023)

Pharmacological Activation of Rev-erbα Attenuates Doxorubicin-Induced Cardiotoxicity by PGC-1α Signaling Pathway
by: Runmei Zou, et al.
Published: (2023)

Trends in the incidence and associated factors of late-onset sepsis associated with improved survival in extremely preterm infants born at 23-26 weeks' gestation: a retrospective study
by: Jin Kyu Kim, et al.
Published: (2018)

Exploring Pediatric Vertebral, Sacral, and Pelvic Osteosarcomas through the NCDB: Demographics, Treatment Utilization, and Survival Outcomes
by: Pemla Jagtiani, et al.
Published: (2024)

Clinical Outcome and Survival of Osteosarcoma Patients in Cipto Mangunkusumo Hospital: Limb Salvage Surgery versus Amputation
by: Achmad Fauzi Kamal, et al.
Published: (2016)

Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis
by: Xiaotong Song, et al.
Published: (2021)